Oncology

The SIOPEL Oncology subcommittee specializes in designing and implementing risk-adapted chemotherapy protocols for pediatric liver tumors. Its primary objective is to optimize treatment efficacy by tailoring regimens to individual risk groups, thereby reducing toxicity while maintaining high cure rates. The committee plays a pivotal role in leading and coordinating international clinical trials, fostering collaboration among centers, and advancing research to continuously refine therapeutic strategies.